dihydroxyphenylalanine has been researched along with Leukemia, Lymphoid in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costea, N | 1 |
| Eipe, J | 1 |
1 other study available for dihydroxyphenylalanine and Leukemia, Lymphoid
| Article | Year |
|---|---|
Erythrocyte antibodies in autoimmune hemolytic anemia.
Topics: Anemia, Hemolytic, Autoimmune; Antibody Specificity; Autoantibodies; Bilirubin; Bone Marrow Examinat | 1974 |